Description:
- Contains the active component Finerenone.
- Belongs to the category of nonsteroidal mineralocorticoid receptor antagonists (MRAs).
- Used to address conditions associated with imbalanced levels of mineralocorticoid hormones, specifically aldosterone.
Uses:
- Treatment of chronic kidney disease (CKD) in individuals diagnosed with type 2 diabetes.
- Helps to slow the progression of kidney disease and reduce the risk of cardiovascular incidents, such as heart failure.
Important Information:
- Do not use if you have hypersensitivity or allergy to the drug or its components.
- Can increase potassium levels in the blood.
- Use cautiously or avoid in patients with hyperkalemia or those taking medications that can increase potassium levels.
- May affect the balance of electrolytes in the body.
- May affect blood glucose levels, especially in patients with diabetes.
- Inform healthcare team about using Kerendia 10mg Tablet before surgery.
Storage:
- Store at controlled room temperature, between 20°C to 25°C (68°F to 77°F).
- Protect the medicine from light and excessive moisture.
- Keep out of reach of children and pets.
Dosage and Administration:
- Follow the prescribed dosage and instructions provided by your healthcare provider.
- Take the medications as directed, usually orally, with or without food.
- Do not skip doses or stop taking them without consulting your healthcare provider.
Safety Advice:
- Pregnancy: may cause harm to an unborn baby. Consult your doctor.
- Breastfeeding: not recommended.
- Lungs: discuss your specific lung condition with your healthcare provider.
- Liver: contraindicated for severe liver impairment. Caution with potential dose adjustments and regular liver function monitoring for mild to moderate liver impairment.
- Alcohol: unsafe to drink alcohol while taking Kerendia 10mg Tablet.
- Driving: can cause dizziness. Avoid driving and operating heavy machinery during treatment.
Side Effects:
- Serious: severe allergic reactions, worsening of kidney function, liver problems, severe hyperkalemia, hypotension leading to fainting or loss of consciousness.
- Common: hyperkalemia, diarrhea, dizziness, fatigue, headache, nausea, hypotension.
FAQ:
Q 1. Can Kerendia 10mg Tablet be used in patients with both heart failure and kidney disease? Kerendia 10mg Tablet is specifically indicated for treating heart failure with reduced ejection fraction (HFrEF) in patients with chronic kidney disease (CKD) and type 2 diabetes.
Q 2. Can Kerendia 10mg Tablet be used in patients with a history of adrenal gland problems? Kerendia 10mg Tablet should be used with caution in patients with adrenal gland problems or adrenal insufficiency.
Q 3. Can Kerendia 10mg Tablet be used in children and adolescents? The safety and efficacy of Kerendia 10mg Tablet in children and adolescents have not been established.
Q 4. Can Kerendia 10mg Tablet cause low blood pressure (hypotension)? The potential side effect of Kerendia 10mg Tablet is low blood pressure, particularly when initiating the medication or increasing the dosage.
Q 5. Can Kerendia 10mg Tablet affect hormone levels in the body? Yes, Kerendia 10mg Tablet can affect hormone levels, particularly those related to the renin-angiotensin-aldosterone system.
Q 6. Can Kerendia 10mg Tablet be used in patients with a history of electrolyte imbalances? Patients with a history of electrolyte imbalances should use Kerendia 10mg Tablet with caution. Regular monitoring of electrolyte levels is essential.
Fact Box:
- Molecule name: Finerenone.
- Therapeutic class: Mineralocorticoid receptor antagonists.
- Pharmacological class: Non-steroidal Mineralocorticoid receptor antagonists (MRAs).
- Indications: Chronic kidney disease (CKD) with type 2 diabetes.